{
    "organizations": [],
    "uuid": "240d0ed0fd725cfe3ad8c647fdfcb798a8c12d2b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-esperite-transfers-its-laboratory/brief-esperite-transfers-its-laboratory-activity-to-geneva-idUSASM000HZL",
    "ord_in_thread": 0,
    "title": "BRIEF-Esperite Transfers Its Laboratory Activity To Geneva",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 10 (Reuters) - Esperite Nv:\n* REG-ESPERITE (ESP) : TRANSFERS ITS LABORATORY ACTIVITY TO GENEVA AND CONSEQUENTLY SELLS ITS BELGIUM LOSS MAKING SUBSIDIARY AND AVOIDS EUR 4 MILLIONS OF FUTURE CASH OUT FOR CHARGES AND FINANCIAL COSTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-10T22:14:00.000+02:00",
    "crawled": "2018-01-11T12:26:39.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "esperite",
        "nv",
        "esp",
        "transfer",
        "laboratory",
        "activity",
        "geneva",
        "consequently",
        "sell",
        "belgium",
        "loss",
        "making",
        "subsidiary",
        "avoids",
        "eur",
        "million",
        "future",
        "cash",
        "charge",
        "financial",
        "cost",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}